Announcing Candidates for CHPAMS 2020-22 BOD & President-elect
Announcing Candidates for CHPAMS 2020-2022 Board of Directors & President-elect
Dear CHPAMS members:
We are pleased to announce the candidates for the China Health Policy and Management Society (CHPAMS) 2020-2022 Board of Directors and President-elect.
The nomination process was open for all registered voting members on January 31, 2020 and closed on March 1, 2020 in pursuant to Article 7 of the CHPAMS Bylaws (http://www.chpams.org/bylaws/). The Nomination Committee deliberated all nominations based on their contributions to science and service to CHPAMS and made the recommendation to the current Board of Directors, who approved the final slate for election. The Nomination Committee includes Dr. Lizheng Shi (Chair, Nomination Committee; President-elect, CHPAMS), Dr. Xi Chen (President, CHPAMS), and Dr. Zhuo (Adam) Chen (Immediate Past President, CHPAMS).
We will use Balloteer (https://www.balloteer.com/) for the election. Balloteer allows anonymized voting with one vote per voting member. Ballot will be sent to the registered email address of voting members. Only the members who registered on www.chpams.org on or before the election day are valid voting members as defined in Article 3 of the CHPAM Bylaws. If you have questions regarding your membership, please contact member@chpams.org.
Once a voting member received a person-specific link for him/her to vote, please note that you can only click the voting button at the bottom of the page (“Cast Your Ballot”) ONCE. You will NOT be able to update your vote once you submit your vote. For the board positions, you may NOT list the same write-in candidate in more than one write-in box. Doing this will invalidate your vote.
Please note that the bylaws require 10% of all voting members to form the quorum for the election. Therefore, we encourage every voting member to cast your vote and make your voice heard. The election will be open on April 18, 2020 and closed on May 4, 2020 (mid-night US Eastern Daylight Savings Time). The results will be announced thereafter.
Thank you very much for your continuous support for CHPAMS.
Sincerely,
Xi Chen
On behalf of the Board of Directors (2018-2020)
http://www.chpams.org/board-of-directors/
China Health Policy and Management Society (CHPAMS)
Candidates for CHPAMS Election 2020
Preside-elect (to take office of President 2022-2024)
Liang Wang, MD, DrPH, MPH, FACE
Dr. Wang is a tenured Associate Professor at ETSU College of Public Health (CPH). He is a Fellow of the American College of Epidemiology. He has been a Visiting Scientist at Harvard T.H.Chan School of Public Health. His research focuses on obesity, nutrition epidemiology, health education and promotion, etc. Dr. Wang has published over 100 peer-reviewed papers (e.g., International Journal of Epidemiology), book chapters (e.g., China Blue Book on Obesity Prevention and Control). He has been a PI and Co-I on multiple grants (e.g., NIH). Dr. Wang has been serving as Board Director of China Health Policy and Management Society (CHPAMS), Associate Director of China-Tennessee Health Education Training Institute, Chair of Public Relations of North America Chinese Society for Nutrition (NACSN), Founding President of the International Chinese Nutrition Young Scholar Network (ICNYSN), Founding President of Institute of Health Education and Lifecourse Promotion (IHELP). He has been awarded NACSN Outstanding Leadership and Service Award in 2016, CPH Dean’s Special Recognition Award for University Leadership Faculty Senate in 2017, Dean’s Special Recognition Award for Service on the Faculty Council in 2017, and College Foundation Service Award in 2018. He was nominated by Dean for University Distinguished Faculty Award for Service in 2019.
Board of Directors 2020-2022
Jing Li, PhD is an Assistant Professor of Health Policy and Economics in the Department of Healthcare Policy and Research at Weill Medical College of Cornell University. Dr. Li obtained her PhD in Health Policy and MA in Economics from University of California, Berkeley. She also holds an MA from Stanford University and a BA from Peking University. A major strand of Dr Li’s research examines the incentives and behaviors of healthcare providers, as well as their impact on healthcare resource allocation, with special focus on the impact among aging population. More generally, she is interested in applying innovative and advanced research methodology in informing relevant questions in healthcare research and policy. Dr. Li has received funding support as PI from sources including the U.S. Agency for Healthcare Research and Quality (AHRQ), Weill Cornell Medicine, Russell Sage Foundation, and Cornell Center for Social Sciences. Her publications have appeared in leading journals including Proceedings of the National Academy of Sciences, Journal of Health Economics, Demography and Medical Care Research and Review. Dr. Li was a recipient of CHPAMS 2018 Rising Scholar Best Paper Award.
Dr. Jinghua Li is an Associate Professor at Department of Health Policy and Management, School of Public Health, Sun Yat-sen University. Dr. Li received her PhD degree from the Chinese University of Hong Kong, Master’s degree (in Global Health Policy) from the University of Tokyo, and Bachelor’s degree (in Building Science and Economics) from Tsinghua University. Her research interests include behavioral health, epidemiological modeling, economic evaluation, focusing on HIV-related research. She has authored/co-authored 36 publications in international peer-reviewed journals. She is the principle investigator of National Natural Science Foundation of China, China Medical Board, and Sun Yet-sen University 100 Talents Scheme.
Chang Liu, PhD is a Regional Director for Singapore, Mainland China, And Hong Kong. Dr. Chang Liu is responsible for the health and aging innovation platforms and leads research and consulting work for ACCESS Health International in the Greater China and ASEAN region. Chang has a held teaching positions at Duke-NUS, the National University of Singapore Enterprise, and the Chinese University of Hong Kong. He has authored a number of publications, including the Singapore overview for the International Profiles of Health Care Systems published by The Commonwealth Fund and London School of Economics. Dr. Liu got his PhD degree of Health Services Research from Brown University, specialized in health economics. He also received Master degree of finance from Guanghua School of Management, Peking University.
Lei Si, PhD is a Senior Research Fellow in Health Economics and Health Systems Research at The George Institute for Global Health. He is a Conjoint Senior Lecturer at UNSW Medicine and an Adjunct Senior Research Fellow at Menzies Institute for Medical Research. He is a current National Health and Medical Research Council (NHMRC) Early Career Fellow. He was the Vice Chairman of the Australian Chinese Association of Biomedical Science, Tasmania Branch (2013-2018) and the Secretary-General of the Chinese Professional Association of Tasmania (2016-2018). He was also a committee member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)–Australia Chapter (2018-2019). Dr. Si has been involved in conducting evaluations of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for the Australian Government. Dr. Si mainly undertakes research in health economic evaluations. In addition, he works on health equality, equity of healthcare financing in China and discrete choice experiment. He has published more than 50 articles in peer-reviewed journals and two book chapters. Dr. Si has received research funding from the National Natural Science Foundation of China, the NHMRC, China Medical Board and so on. Dr. Si is an Associate Editor of BMJ Global Health and BMC Musculoskeletal Disorders.
Huiwen Xu, PhD is a Research Assistant Professor at University of Rochester Medical Center. He received his PhD in Health Services Research and Policy with Data Science training from University of Rochester. Dr. Xu’s research focuses on applying advanced statistical methods and machine learning to examine quality of care in long term care setting with Minimum Data Set and Medicare claims, improving quality of life among older patients with cancer, and reducing rural-urban disparities in the U.S. and China. So far, Dr. Xu coauthored 25 peer-reviewed articles, including leading medical journals like JAMA Oncology, Medical Care, and Journal of American Medical Directors Association; he also coauthored over 50 scientific abstracts and actively presented his work at national and international conferences. He is a SAS certified programmer with 3 certifications (Basic, Advanced, and Statistical Business Analyst) and cofounded the Rochester Data Science Society in 2016. During 2017-2019, he served the Advisory Committee of AcademyHealth LTSS Interest Group. Dr. Xu also serves as an ad hoc reviewer for 10 scientific journals including JAMA Network Open. Dr. Xu received several awards, including the Poster Award from Denver Post-Acute Care Conference, Student Volunteer Award from AcademyHealth LTSS Interest Group, and Travel Fellowship from CHPAMS.
Donglan Zhang, Ph.D., is an Assistant Professor of Health Policy and Management at the University of Georgia. Professor Zhang previously worked as a prevention effectiveness fellow at the Centers for Disease Control and Prevention. Her research focuses on health insurance coverage and access to health care, telemedicine, health disparities, policy simulation and prevention of chronic diseases in the United States and China. Professor Zhang's research has been funded by NIH, USDA, and other local funding sources. She has published more than 60 peer-reviewed articles with some on top health policy and public health journals. She recently received an NIH R01 grant to study the rural-urban disparities in cardiovascular diseases and how local and state policies in the clinical and community systems help mitigate these disparities. Her study on telemedicine and stroke care was published in Health Affairs and presented at the national press club and received the China Health Policy and Management Society Rising Scholar Best Paper award of 2018. Her research on nutrition labeling and sodium intake, telemedicine, rural physician shortages, and rural-urban health disparities and policies has been featured in local and national media. Dr. Zhang received her Ph.D. in Health Policy and Management from UCLA in 2014.
Mengxi Zhang, Ph.D., MPH, is an Assistant Professor in Health Science at Ball State University. She graduated from Tulane University with her Ph.D. in International Health and Development and Master Degree in Epidemiology. Prior to Tulane, she majored in Preventive Medicine in Capital Medical University. Her research focuses mainly on health promotion among refugees in the United States and immigrants in Southeast Asia. She is also interested in maternal and child health in minority groups. She has received various awards recognizing her work, including the Best Dissertation Award from Tulane University and Mekong Region Scholars Award from the University of Utah.